XTL Biopharmaceuticals Ltd. (XTLB)
NASDAQ: XTLB · Real-Time Price · USD
1.440
+0.025 (1.77%)
Aug 14, 2025, 9:35 AM - Market open
XTL Biopharmaceuticals Employees
XTL Biopharmaceuticals had 10 employees as of December 31, 2024. The number of employees increased by 3 or 42.86% compared to the previous year.
Employees
10
Change
3
Growth
42.86%
Revenue / Employee
$45,100
Profits / Employee
-$102,700
Market Cap
13.02M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 10 | 3 | 42.86% |
| Dec 31, 2016 | 7 | 1 | 16.67% |
| Dec 31, 2015 | 6 | 1 | 20.00% |
| Dec 31, 2014 | 5 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
XTLB News
- 4 months ago - XTL Names Mr. Noam Band as its New Chief Executive Officer - GlobeNewsWire
- 1 year ago - XTL Completed the Acquisition of The Social Proxy and a Private Placement of $1.5 Million - GlobeNewsWire
- 1 year ago - XTL Entered Definitive Agreement to Acquire The Social Proxy - GlobeNewsWire
- 1 year ago - XTL To Aquire The Social Proxy - GlobeNewsWire
- 1 year ago - XTL Biopharmaceuticals Confirms that it has not Experienced any Disruption to its Business Operations in Israel - GlobeNewsWire
- 1 year ago - XTL Biopharmaceuticals Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency - GlobeNewsWire
- 4 years ago - Dr. Morris C. Laster Files Preliminary Proxy Statement Nominating Two Highly-Qualified Individuals For Election To Board At Scopus BioPharma Inc.'s 2021 Annual Meeting - PRNewsWire